_reaction-cathie-wood-on-crispr-amp-genomic-stocks-preview-1.jpg "Reaction: Cathie Wood on CRISPR & Genomic Stocks from oscine therapeutics Video Screenshot Preview 1")
Gallery_reaction-cathie-wood-on-crispr-amp-genomic-stocks-preview-3.jpg "Reaction: Cathie Wood on CRISPR & Genomic Stocks from oscine therapeutics Video Screenshot Preview 3")
Gallery_reaction-cathie-wood-on-crispr-amp-genomic-stocks-preview-hqdefault.jpg "Reaction: Cathie Wood on CRISPR & Genomic Stocks from oscine therapeutics Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 9 minutes 37 seconds
👁 View: 2.7K times
Play Audio:👁 View: 2.7K times
Description:
The Market Mindset
The Market Mindset
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_the-ceo-of-this-innovative-biopharma-is-bringing-light-to-cancer-research.webp "Paul Peter Tak, MD, PhD, FMedSci, President & CEO of Candel Therapeutics, was recently a guest on Benzinga's All-Acess.<br/><br/>Candel is a clinical-stage biopharmaceutical company focused on developing immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The company has two main platforms that are currently undergoing clinical trials. <br/><br/>Candel also has its enLIGHTEN™ program, a systematic, iterative discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors.")
_episode-3-how-to-start-your-own-biotech-company-part-1-therapeutics.webp "NCI Scientific Events and Resources")
_2024-ceo-chat-conley-chee-ceo-of-syros-pharmaceuticals.webp "Flagship Pioneering")
_cathie-wood-9234mark-my-words-everyone-who-own-these-3-stocks-will-become-millionaire-by-end-of-20249234.webp "Millionaires Investment Secrets")
⏲ 14 minutes 56 seconds 👁 250.1K
_crispr39s-next-advance-is-bigger-than-you-think-124-jennifer-doudna-124-ted.webp "TED")
⏲ 7 minutes 37 seconds 👁 335.4K
_crsp-stock-on-wild-ride-after-fda39s-historic-approval-these-gene-editing-treatments-could-be-next.webp "Alexis Garcia")
⏲ 15 minutes 51 seconds 👁 55K
_the-age-of-crispr-engineering-the-future-of-genetic-medicine-124-benjamin-oakes-124-tedxberkeley.webp "TEDx Talks")
⏲ 15 minutes 25 seconds 👁 518
_intellia-stock-vs-crispr-stock-the-winner-is.webp "Nanalyze")
_the-ceo-of-this-innovative-biopharma-is-bringing-light-to-cancer-research.jpg)
_episode-3-how-to-start-your-own-biotech-company-part-1-therapeutics.jpg)
_2024-ceo-chat-conley-chee-ceo-of-syros-pharmaceuticals.jpg)
_cathie-wood-9234mark-my-words-everyone-who-own-these-3-stocks-will-become-millionaire-by-end-of-20249234.jpg)
_crispr39s-next-advance-is-bigger-than-you-think-124-jennifer-doudna-124-ted.jpg)
_crsp-stock-on-wild-ride-after-fda39s-historic-approval-these-gene-editing-treatments-could-be-next.jpg)
_the-age-of-crispr-engineering-the-future-of-genetic-medicine-124-benjamin-oakes-124-tedxberkeley.jpg)
_intellia-stock-vs-crispr-stock-the-winner-is.jpg)
![[+]](/images/menu.gif){kind=small}